Literature DB >> 33288651

Diabetic Foot Care Before and During the COVID-19 Epidemic: What Really Matters?

Vilma Urbančič-Rovan1.   

Abstract

Entities:  

Year:  2020        PMID: 33288651      PMCID: PMC7818319          DOI: 10.2337/dc20-2650

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
The coronavirus disease 2019 (COVID-19) epidemic reached Europe at the beginning of the year 2020. It posed an enormous toll on people and the economy and had a significant impact on health care systems. Health care delivery had to be modified in order to fulfill the increased demands due to the epidemic and to prevent infection spread. The first case in Slovenia (2,095,861 inhabitants) was confirmed on 4 March 2020. The COVID-19 epidemic was officially declared on 12 March. All preventative medical activities, including those of foot clinics (foot screening and perfusion pressure measurement) were suspended by a decree of the government and fully resumed only after 15 May 2020. The outpatient foot clinic at University Medical Centre Ljubljana has been running daily without limitations since then (with two full-time and one part-time nurse and one doctor, a consultant diabetologist), in spite of the strong second wave that began in mid-August. During the lockdown period, the clinic remained open for all foot ulcer patients without signs or symptoms of COVID-19 who have not been in contact with COVID-19 patients. Strict measures to limit infection spread were introduced: precise timing of the appointments, health status questionnaire and body temperature measurement before entering the clinic, and minimum distance of 1.5 m between the chairs in the waiting room. Laboratory tests, imaging procedures, microbiology testing, emergency vascular diagnostic and therapeutic procedures, and emergency surgical procedures were accessible all the time. Telephone and e-mail consultations were introduced to reduce the number of patients attending the clinic. The comparison between the amount of work done in 2019 and in 2020 is shown in Table 1.
Table 1

Activities of the foot clinic in 2019 and 2020

2019, N/month2020,* N/month2019, total N2020, total N2020/2019
Jan-DecJan-FebMar-AprMay-JunJul-AugJan-AugJan-Aug
Clinic visits4685222213953123,4992,8980.83
Foot screening23427868195951,6841,2700.75
Ankle/brachial index88771966416624030.61
Foot ulcer2742831642432692,1191,9180.91
Wound swab221371216180940.52
Emergency67593960575064270.84

Lockdown period: 12 March–5 May.

Activities of the foot clinic in 2019 and 2020 Lockdown period: 12 March–5 May. Several reports from foot clinics have been published in the recent months (1,2). The common denominator of all of them is a significantly reduced number of clinic visits and introduction of telemedicine in diabetic foot care. In their “tale of two cities,” Shin et al. (1) report a nearly 50% drop in foot clinic visits in Manchester (U.K.) (population over 3 million) and nearly 70% drop in Los Angeles (U.S.) (population of about 10 million) after lockdown. The number of clinic visits at the outpatient foot clinic at Ljubljana University Medical Centre (catchment area of 400,000 inhabitants) in the prelockdown period (January + February) was twice as many per capita as in Manchester and almost three times as many as in Los Angeles. During the lockdown period (March + April), the total number of clinic visits dropped by 58%, mainly due to a significant reduction in foot screening, but also foot ulcer visits and emergency visits dropped by 42% and 34%, respectively. In the following months, the numbers went up; the number of foot screenings in August 2020 was more than double that in August 2019. Still, except for foot ulcer and emergency visits, the 2019 figures were not reached. Patients with loss of protective sensation are at risk for foot ulceration and may neglect the warning signs of ulcer and infection. Regular foot screening plays a significant role in ulcer prevention, and good access to the foot clinics is essential for efficient wound healing and limb salvage. Lockdown of foot clinics with complete suspension of preventative and partial suspension of curative activities may lead to unforeseen long-term consequences—increased number of complicated foot ulcers and higher amputation rate. The COVID-19 pandemic is a big challenge for health care systems worldwide. New solutions had to be found almost overnight and a lot of creativity was necessary. Guidelines on COVID-19 and diabetic foot disease by the International Working Group on the Diabetic Foot (3) were not available at the outbreak of the epidemic. We had to overcome several barriers: as public transport was not operating, many patients had difficulties getting to the clinic, and some of them skipped the scheduled visits because of fear of infection. However, we have kept active: telephone and e-mail consultations for patients and primary care physicians were introduced, and we aimed for good responsiveness and encouraged the patients to contact us immediately in case of foot problems. All team members followed the preventative measures strictly and did their best to create a calm, positive atmosphere without unnecessary panic at the clinic. No infection spread from outside was recorded. Our approach was well appreciated by the patients. Undoubtedly, the COVID-19 epidemic will lead to significant irreversible changes in diabetic foot care delivery (4).
  3 in total

1.  Post the Pandemic: How will COVID-19 Transform Diabetic Foot Disease Management?

Authors:  Bijan Najafi
Journal:  J Diabetes Sci Technol       Date:  2020-06-09

Review 2.  Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities.

Authors:  Laura Shin; Frank L Bowling; David G Armstrong; Andrew J M Boulton
Journal:  Diabetes Care       Date:  2020-06-12       Impact factor: 19.112

3.  The COVID-19 Outbreak Negatively Affects the Delivery of Care for Patients With Diabetic Foot Ulcers.

Authors:  Chao Liu; Jiaxing You; Weifen Zhu; Yixin Chen; Shengyun Li; Yuefeng Zhu; Shujuan Ji; Ying Wang; Hongye Li; Lin Li; Shunwu Fan
Journal:  Diabetes Care       Date:  2020-08-07       Impact factor: 19.112

  3 in total
  7 in total

1.  Impact of COVID-19 pandemic on foot care services in Ontario, Canada.

Authors:  Suzanne H Lu; Ann-Marie McLaren; Ellie Pinsker
Journal:  J Foot Ankle Res       Date:  2022-06-24       Impact factor: 3.050

Review 2.  Diabetic Foot Disease during the COVID-19 Pandemic.

Authors:  Andrew J M Boulton
Journal:  Medicina (Kaunas)       Date:  2021-01-22       Impact factor: 2.430

3.  A Population-Based Analysis of Diabetes-Related Care Measures, Foot Complications, and Amputation During the COVID-19 Pandemic in Ontario, Canada.

Authors:  Charles de Mestral; David Gomez; Andrew S Wilton; Douglas S Lee; Zaina Albalawi; Peter C Austin; Jean Jacob-Brassard; David R Urbach; Mohammed Al-Omran; Nancy N Baxter
Journal:  JAMA Netw Open       Date:  2022-01-04

4.  Breakdown of Diabetic Foot Ulcer Care during the First Year of the Pandemic in Poland: A Retrospective National Cohort Study.

Authors:  Marcin Kleibert; Beata Mrozikiewicz-Rakowska; Patrycja Małgorzata Bąk; Daniel Bałut; Jakub Zieliński; Leszek Czupryniak
Journal:  Int J Environ Res Public Health       Date:  2022-03-23       Impact factor: 3.390

5.  Covid-19 lockdown showed a likely beneficial effect on diabetic foot ulcers.

Authors:  Jean-Baptiste Bonnet; Valérie Macioce; Abdulkader Jalek; Karim Bouchdoug; Cécile Elleau; Marie-Françoise Gras-Vidal; Julie Pochic; Antoine Avignon; Ariane Sultan
Journal:  Diabetes Metab Res Rev       Date:  2022-02-02       Impact factor: 8.128

6.  Effects of the COVID-19 pandemic on the outcome and mortality of patients with diabetic foot ulcer.

Authors:  Guy Rubin; Guy Feldman; Inon Dimri; Arthur Shapiro; Nimrod Rozen
Journal:  Int Wound J       Date:  2022-05-05       Impact factor: 3.099

7.  Diabetic foot disease during the COVID-19 pandemic: lessons learned for our future.

Authors:  Cesare Miranda; Giorgio Zanette; Roberto Da Ros
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.